Healsun Biopharm

company

About

Healsun Biopharm is a pharmaceutical company.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
¥250M
Industries
Biopharma,Biotechnology,Health Care,Information Technology,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥250M
Healsun Biopharm has raised a total of ¥250M in funding over 2 rounds. Their latest funding was raised on Aug 19, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 19, 2022 Series B ¥250M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
Healsun Biopharm is funded by 3 investors. Orient Jiafu Asset Management and Xinghua Dingli are the most recent investors.
Investor Name Lead Investor Funding Round
Orient Jiafu Asset Management Series B
Xinghua Dingli Series B
HT Capital Series B